Publications
Specialty
Search
Advances in Inflammatory Bowel Disease Network
09/18/2024
Dr Ashburn explains the surgical techniques that can help relieve pain and promote healing for patients with perianal and fistulizing Crohn's disease.
Journal of Clinical Pathways
09/18/2024
Luke Pike, MD, shares key takeaways from the TURBO-Non–Small Cell Lung Cancer study and highlights promising studies on the horizon for EGFR mutant NSCLC treatment.
Vascular Disease Management, CardioVascular
09/18/2024
In this video recorded at AMP 2024, Dr. Ramon Varcoe discusses 2 of his AMP presentations on the results and indications of the LIFE-BTK and RESOLV studies.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
09/18/2024
A transparent AI approach recalibrated the new PREVENT equations to provide a more tailored cardiovascular risk assessment in a local population.
ePlasty, Surgery
09/18/2024
This study examines the use of polydioxanone (PDO) mesh in 522 breast implant surgeries to enhance aesthetic outcomes.
Rheumatology & Arthritis
09/18/2024
Upadacitinib was associated with significant improvements in several key outcomes, including low disease activity.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular, EP Lab Digest
09/18/2024
The global prevalence of congenital heart disease is higher among women who live in high altitudes, according to a new study being presented at ACC Latin America 2024 in Punta Cana, Dominican Republic.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular, Vascular Disease Management
09/18/2024
The PMA application is based on the overwhelmingly positive one-year data from the Company’s C-GUARDIANS pivotal clinical trial that were presented at the Leipzig Interventional Course (LINC) 2024 in May.
First Report Managed Care, Population Health
09/18/2024
The aftermath of legal challenges and state legislation continues to reshape the landscape of copay accumulator programs, forcing payers and manufacturers to adapt their strategies.
Oncology
09/18/2024
Based on results from the KEYNOTE-483 study, the US FDA has approved pembrolizumab plus pemetrexed and platinum-based chemotherapy as first-line treatment for patients with unresectable advanced or metastatic malignant pleural mesothelioma.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
09/18/2024
Individuals released from jail are more likely to have uncontrolled cardiovascular disease (CVD) risk factors than those released from prison, a new Yale-led study finds.
Rheumatology & Arthritis
09/18/2024
Bone loss has been found to play a significant role in axial spondyloarthritis (axSpA) and reg
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular, Vascular Disease Management
09/17/2024
Silk Road Medical, Inc., is a medical device company that pioneered a new approach for stroke prevention and the treatment of carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization (TCAR).
Wounds
09/17/2024
Objective: To retrospectively assess the effect of polylactic acid in promoting chronic wound healing compared with 2 other well-established cellular, acellular, and matrix-like products.
Oncology
09/17/2024
Jamie Chaft, MD, discusses the 5-year follow-up data from the IMpower010 trial which showed atezolizumab continued to provide greater improvement to disease-free survival than best supportive care for patients with resectable early-stage non-small cell lung cancer, regardless of disease stage or regional lymph node status.
EP Lab Digest
09/17/2024
iCardio.ai is announcing a collaboration with Abbott to develop artificial intelligence applications for its imaging devices.
Oncology
09/17/2024
Gabriela Hobbs, MD, provides an overview of the latest strategies and updates regarding the management and treatment of patients with polycythemia vera.
Oncology
09/17/2024
On September 17, 2024, the FDA approved ribociclib with an aromatase inhibitor as well as a ribociclib and letrozole co-pack for the adjuvant treatment of adults with hormone receptor-positive, HER2-negative stage II and III early breast cancer.
First Report Managed Care
09/17/2024
Discover how Kindred Hospitals, a national network of long-term acute care hospitals (LTACHs), are improving patient outcomes and reducing health care costs for complex wound patients through their advanced wound care program.
Today's Wound Clinic, Wound Care
09/17/2024
Why does MIPS seem irrelevant to most wound care practitioners? A brief history of how we got here.